Head of Target Discovery, Milner Therapeutics Institute
Rebecca Harris leads the experimental research programme within the Centre for Pathway Analysis there, working on collaborative projects with Cambridge academics to develop clinically relevant, well validated targets for disease therapy. Rebecca also works closely with the CRUK Cambridge Centre to support the conversion of preclinical oncology research to clinical impact, through research, industry engagement and entrepreneurship. Learn more.
Research AreasCell biology
Target validation
Drug discovery
Oncology
Inflamamatory disease
|
TechniquesLive cell imaging
Complex cell assays
Organoids
CRISPR
Hypoxic assays
|
Areas for CollaborationTarget identification
Target validation
Drug discovery
Complex cell assays
Tumour microenvironment
|
Research Theme
